Reviews Delestrogen


No reviews yet.

Delestrogen Drug Description
DELESTROGEN®
(estradiol valerate) Injection, USP

ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER
Close clinical surveillance of all women taking estrogens is important. Adequate
diagnostic measures, including endometrial sampling when indicated, should
be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. There is no evidence that the use
of "natural" estrogens results in a different endometrial risk profile
than synthetic estrogens at equivalent estrogen doses. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.)
CARDIOVASCULAR AND OTHER RISKS
Estrogens and progestins should not be used for the prevention of cardiovascular
disease. (See WARNINGS, Cardiovascular disorders.)
The Women's Health Initiative (WHI) study reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein
thrombosis in postmenopausal women (50 to 79 years of age) during 5 years
of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone
acetate (MPA 2.5 mg) relative to placebo. (See CLININAL PHARMACOLOGY, Clinical
Studies.) The Women's Health Initiative Memory Study (WHIMS), a substudy
of WHI, reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 4 years of treatment with oral conjugated
estrogens plus medroxyprogesterone acetate relative to placebo. It is unknown
whether this finding applies to younger postmenopausal women or to women taking
estrogen alone therapy. (See CLINICAL PHARMACOLOGY, Clinical
Studies.)
Other doses of oral conjugated estrogens with medroxyprogesterone acetate,
and other combinations and dosage forms of estrogens and progestins were not
studied in the WHI clinical trials and, in the absence of comparable data, these
risks should be assumed to be similar. Because of these risks, estrogens with
or without progestins should be prescribed at the lowest effective doses and
for the shortest duration consistent with treatment goals and risks for the
individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol injection?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or...
Read All Potential Side Effects for Delestrogen »




DELESTROGEN® (estradiol valerate injection, USP) contains estradiol valerate, a long-acting estrogen in sterile oil solutions for intramuscular use. These solutions are clear, colorless to pale yellow. Formulations (per mL): 10 mg estradiol valerate in a vehicle containing 5 mg chlorobutanol (chloral derivative/preservative) and sesame oil; 20 mg estradiol valerate in a vehicle containing 224 mg benzyl benzoate, 20 mg ben-zyl alcohol (preservative), and castor oil; 40 mg estradiol valerate in a vehicle containing 447 mg benzyl benzoate, 20 mg benzyl alcohol, and castor oil.
Estradiol valerate is designated chemically as estra-1,3,5(10)-triene-3, 17-diol(17β)-, 17-pentanoate. Graphic formula:







C23H32O3...................MW
356.50
Last reviewed on RxList: 9/18/2008




Delestrogen Drug Description
DELESTROGEN®
(estradiol valerate) Injection, USP

ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER
Close clinical surveillance of all women taking estrogens is important. Adequate
diagnostic measures, including endometrial sampling when indicated, should
be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. There is no evidence that the use
of "natural" estrogens results in a different endometrial risk profile
than synthetic estrogens at equivalent estrogen doses. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.)
CARDIOVASCULAR AND OTHER RISKS
Estrogens and progestins should not be used for the prevention of cardiovascular
disease. (See WARNINGS, Cardiovascular disorders.)
The Women's Health Initiative (WHI) study reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein
thrombosis in postmenopausal women (50 to 79 years of age) during 5 years
of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone
acetate (MPA 2.5 mg) relative to placebo. (See CLININAL PHARMACOLOGY, Clinical
Studies.) The Women's Health Initiative Memory Study (WHIMS), a substudy
of WHI, reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 4 years of treatment with oral conjugated
estrogens plus medroxyprogesterone acetate relative to placebo. It is unknown
whether this finding applies to younger postmenopausal women or to women taking
estrogen alone therapy. (See CLINICAL PHARMACOLOGY, Clinical
Studies.)
Other doses of oral conjugated estrogens with medroxyprogesterone acetate,
and other combinations and dosage forms of estrogens and progestins were not
studied in the WHI clinical trials and, in the absence of comparable data, these
risks should be assumed to be similar. Because of these risks, estrogens with
or without progestins should be prescribed at the lowest effective doses and
for the shortest duration consistent with treatment goals and risks for the
individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol injection?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or...
Read All Potential Side Effects for Delestrogen »




DELESTROGEN® (estradiol valerate injection, USP) contains estradiol valerate, a long-acting estrogen in sterile oil solutions for intramuscular use. These solutions are clear, colorless to pale yellow. Formulations (per mL): 10 mg estradiol valerate in a vehicle containing 5 mg chlorobutanol (chloral derivative/preservative) and sesame oil; 20 mg estradiol valerate in a vehicle containing 224 mg benzyl benzoate, 20 mg ben-zyl alcohol (preservative), and castor oil; 40 mg estradiol valerate in a vehicle containing 447 mg benzyl benzoate, 20 mg benzyl alcohol, and castor oil.
Estradiol valerate is designated chemically as estra-1,3,5(10)-triene-3, 17-diol(17β)-, 17-pentanoate. Graphic formula:







C23H32O3...................MW
356.50
Last reviewed on RxList: 9/18/2008




Delestrogen Drug Description
DELESTROGEN®
(estradiol valerate) Injection, USP

ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER
Close clinical surveillance of all women taking estrogens is important. Adequate
diagnostic measures, including endometrial sampling when indicated, should
be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. There is no evidence that the use
of "natural" estrogens results in a different endometrial risk profile
than synthetic estrogens at equivalent estrogen doses. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.)
CARDIOVASCULAR AND OTHER RISKS
Estrogens and progestins should not be used for the prevention of cardiovascular
disease. (See WARNINGS, Cardiovascular disorders.)
The Women's Health Initiative (WHI) study reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein
thrombosis in postmenopausal women (50 to 79 years of age) during 5 years
of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone
acetate (MPA 2.5 mg) relative to placebo. (See CLININAL PHARMACOLOGY, Clinical
Studies.) The Women's Health Initiative Memory Study (WHIMS), a substudy
of WHI, reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 4 years of treatment with oral conjugated
estrogens plus medroxyprogesterone acetate relative to placebo. It is unknown
whether this finding applies to younger postmenopausal women or to women taking
estrogen alone therapy. (See CLINICAL PHARMACOLOGY, Clinical
Studies.)
Other doses of oral conjugated estrogens with medroxyprogesterone acetate,
and other combinations and dosage forms of estrogens and progestins were not
studied in the WHI clinical trials and, in the absence of comparable data, these
risks should be assumed to be similar. Because of these risks, estrogens with
or without progestins should be prescribed at the lowest effective doses and
for the shortest duration consistent with treatment goals and risks for the
individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol injection?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or...
Read All Potential Side Effects for Delestrogen »




DELESTROGEN® (estradiol valerate injection, USP) contains estradiol valerate, a long-acting estrogen in sterile oil solutions for intramuscular use. These solutions are clear, colorless to pale yellow. Formulations (per mL): 10 mg estradiol valerate in a vehicle containing 5 mg chlorobutanol (chloral derivative/preservative) and sesame oil; 20 mg estradiol valerate in a vehicle containing 224 mg benzyl benzoate, 20 mg ben-zyl alcohol (preservative), and castor oil; 40 mg estradiol valerate in a vehicle containing 447 mg benzyl benzoate, 20 mg benzyl alcohol, and castor oil.
Estradiol valerate is designated chemically as estra-1,3,5(10)-triene-3, 17-diol(17β)-, 17-pentanoate. Graphic formula:







C23H32O3...................MW
356.50
Last reviewed on RxList: 9/18/2008




Delestrogen Drug Description
DELESTROGEN®
(estradiol valerate) Injection, USP

ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER
Close clinical surveillance of all women taking estrogens is important. Adequate
diagnostic measures, including endometrial sampling when indicated, should
be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. There is no evidence that the use
of "natural" estrogens results in a different endometrial risk profile
than synthetic estrogens at equivalent estrogen doses. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.)
CARDIOVASCULAR AND OTHER RISKS
Estrogens and progestins should not be used for the prevention of cardiovascular
disease. (See WARNINGS, Cardiovascular disorders.)
The Women's Health Initiative (WHI) study reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein
thrombosis in postmenopausal women (50 to 79 years of age) during 5 years
of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone
acetate (MPA 2.5 mg) relative to placebo. (See CLININAL PHARMACOLOGY, Clinical
Studies.) The Women's Health Initiative Memory Study (WHIMS), a substudy
of WHI, reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 4 years of treatment with oral conjugated
estrogens plus medroxyprogesterone acetate relative to placebo. It is unknown
whether this finding applies to younger postmenopausal women or to women taking
estrogen alone therapy. (See CLINICAL PHARMACOLOGY, Clinical
Studies.)
Other doses of oral conjugated estrogens with medroxyprogesterone acetate,
and other combinations and dosage forms of estrogens and progestins were not
studied in the WHI clinical trials and, in the absence of comparable data, these
risks should be assumed to be similar. Because of these risks, estrogens with
or without progestins should be prescribed at the lowest effective doses and
for the shortest duration consistent with treatment goals and risks for the
individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol injection?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or...
Read All Potential Side Effects for Delestrogen »




DELESTROGEN® (estradiol valerate injection, USP) contains estradiol valerate, a long-acting estrogen in sterile oil solutions for intramuscular use. These solutions are clear, colorless to pale yellow. Formulations (per mL): 10 mg estradiol valerate in a vehicle containing 5 mg chlorobutanol (chloral derivative/preservative) and sesame oil; 20 mg estradiol valerate in a vehicle containing 224 mg benzyl benzoate, 20 mg ben-zyl alcohol (preservative), and castor oil; 40 mg estradiol valerate in a vehicle containing 447 mg benzyl benzoate, 20 mg benzyl alcohol, and castor oil.
Estradiol valerate is designated chemically as estra-1,3,5(10)-triene-3, 17-diol(17β)-, 17-pentanoate. Graphic formula:







C23H32O3...................MW
356.50
Last reviewed on RxList: 9/18/2008




Delestrogen Drug Description
DELESTROGEN®
(estradiol valerate) Injection, USP

ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER
Close clinical surveillance of all women taking estrogens is important. Adequate
diagnostic measures, including endometrial sampling when indicated, should
be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. There is no evidence that the use
of "natural" estrogens results in a different endometrial risk profile
than synthetic estrogens at equivalent estrogen doses. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.)
CARDIOVASCULAR AND OTHER RISKS
Estrogens and progestins should not be used for the prevention of cardiovascular
disease. (See WARNINGS, Cardiovascular disorders.)
The Women's Health Initiative (WHI) study reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein
thrombosis in postmenopausal women (50 to 79 years of age) during 5 years
of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone
acetate (MPA 2.5 mg) relative to placebo. (See CLININAL PHARMACOLOGY, Clinical
Studies.) The Women's Health Initiative Memory Study (WHIMS), a substudy
of WHI, reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 4 years of treatment with oral conjugated
estrogens plus medroxyprogesterone acetate relative to placebo. It is unknown
whether this finding applies to younger postmenopausal women or to women taking
estrogen alone therapy. (See CLINICAL PHARMACOLOGY, Clinical
Studies.)
Other doses of oral conjugated estrogens with medroxyprogesterone acetate,
and other combinations and dosage forms of estrogens and progestins were not
studied in the WHI clinical trials and, in the absence of comparable data, these
risks should be assumed to be similar. Because of these risks, estrogens with
or without progestins should be prescribed at the lowest effective doses and
for the shortest duration consistent with treatment goals and risks for the
individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol injection?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or...
Read All Potential Side Effects for Delestrogen »




DELESTROGEN® (estradiol valerate injection, USP) contains estradiol valerate, a long-acting estrogen in sterile oil solutions for intramuscular use. These solutions are clear, colorless to pale yellow. Formulations (per mL): 10 mg estradiol valerate in a vehicle containing 5 mg chlorobutanol (chloral derivative/preservative) and sesame oil; 20 mg estradiol valerate in a vehicle containing 224 mg benzyl benzoate, 20 mg ben-zyl alcohol (preservative), and castor oil; 40 mg estradiol valerate in a vehicle containing 447 mg benzyl benzoate, 20 mg benzyl alcohol, and castor oil.
Estradiol valerate is designated chemically as estra-1,3,5(10)-triene-3, 17-diol(17β)-, 17-pentanoate. Graphic formula:







C23H32O3...................MW
356.50
Last reviewed on RxList: 9/18/2008





Other reviews about Delestrogen on wordpress

Oh my aching head!
  by singlikesassy
I get lowgrade migraine headaches the day after my delestrogen shots. I've had to resort to taking Advil which bothers me because I hate to take meds unless […]


Step 3: Insert needle, press plunger
  by singlikesassy
Went to the doc this a.m. and it seems like all is on track. My body has responded to the meds as they had anticipated and my nurse […]


A Dud
  by perchancetodream
7/8 dpiui I think this cycle is a dud.  The clinic just called. Estrogen: 882 Progesterone: 58 HCG: 3 (9 days after trigger) They're doubling (and in some case tripling my progesterone/delestrogen/prometrium.  Honestly, […]


Monday Monday
  by dolcib
Every other day, every other day, Every other day of the week is fine, yeah But whenever Monday comes, but whenever Monday comes You can find me cryin' all of the […]


Stims and Such
  by dolcib
Our donor starts stims today!!! I was surprised that SG actually called to tell me this. My nurse said that my donor is very appropriate and conscientious when it […]


Recycling
  by happymamab
I started my period today! It is officially day one of our new cycle. Now I have to go in for blood work to make sure all of […]


Stellar!
  by happymamab
The word to describe my uterine lining today was "stellar"! I have a triple-layer forming which is perfect for implantation and am measuring 12.2mm. Yay! We are increasing […]


First Lining Check - 23 July 07
  by pinkyb
I went in for my first lining check of this cycle since starting the viagara suppositories last week. I was a bit nervous considering that I've only been on […]


4 Days Left? - 30 July 07
  by pinkyb
My transfer is on Friday. Today is Monday. Does that mean I have 4 days left? I was up until 3:30am this morning - anxious...butterflies in my tummy. I want so badly […]


Delestrogen Freak Out
  by aathatcher
So today I had my first of probably many "freak outs" of this fertility cycle. This morning I had to begin a new shot, which is intramuscular (IM). This […]



Other reviews about Delestrogen on web:

Learn about the prescription medication Delestrogen (Estradiol valerate), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Delestrogen (Estradiol valerate) Drug Information: Uses, Side ...


All about Delestrogen. View complete and up to date Delestrogen information - part of the Drugs.com trusted medication database. Delestrogen Facts and Comparisons at Drugs.com


Accurate, FDA approved Delestrogen information for healthcare professionals and patients - brought to you by Drugs.com. Delestrogen Official FDA information, side effects and uses.


This medicine is an estrogen hormone used to treat certain symptoms of menopause or to prevent osteoporosis (weakened bones/bone loss). It is also used to treat breast cancer and ... Delestrogen Resource Site


Delestrogen is an estrogen hormone used to treat certain symptoms of menopause or to prevent osteoporosis (weakened bones/bone loss). Side effects and interactions are available at ... Delestrogen - drugstore.com. Low prices, side effects, interactions.


Consumer information about the medication ESTRADIOL VALERATE - INJECTION (Delestrogen), includes side effects, drug interactions, recommended dosages, and storage information. ESTRADIOL VALERATE - INJECTION (Delestrogen) side effects, medical ...


Delestrogen is prescribed to treat menopausal symptoms, hormone deficiencies, and advanced prostate cancer. This eMedTV Web resource provides an overview of Delestrogen, including ... Delestrogen


There is no indication for DELESTROGEN in pregnancy. There appears to be little or no increased risk of birth defects in children ... JHP Pharmaceuticals


Delestrogen side effects, dosage, and drug interactions. All accurate, up-to-date information is written for the consumer by healthcare professionals. Delestrogen IM Uses and How to Use


What is Delestrogen (Estradiol)? Estradiol is a form of estrogen. Estrogen is a female sex hormone necessary for many processes in the body. Estradiol injection is used to treat ... Delestrogen - Drugs & Treatments - Revolution Health





Featured Reviews

Reviews Halcinonide Topical Solution

Halog Solution Drug Description HALOG® SOLUTION (halcinonide) Topical Solution, USP 0.1% For Topical Use Only. Not For Ophthalmic Use. DRUG DESCRIPTION What are the possible side effects of halcinonide topical (Halog,...
Read More  |  Review This
Reviews Fosamax Plus D

Fosamax Plus D Drug Description FOSAMAX PLUS D® (alendronate sodium/cholecalciferol) Tablets DRUG DESCRIPTION What are the possible side effects of alendronate and cholecalciferol (Fosamax Plus D)? Get emergency medical help...
Read More  |  Review This
Reviews Cipro

Cipro Drug Description CIPRO® (ciprofloxacin hydrochloride) Tablets CIPRO® (ciprofloxacin*) Oral Suspension WARNING Fluoroquinolones, including CIPRO®, are associated with an increased risk of tendinitis and tendon rupture...
Read More  |  Review This
Reviews Clindamycin Benzoyl Peroxide

Duac Topical Gel Drug Description Duac® Topical Gel (clindamycin, 1% - benzoyl peroxide, 5%) For Dermatological Use Only. Not for Ophthalmic Use. DRUG DESCRIPTION What are the possible side effects of benzoyl peroxide and...
Read More  |  Review This
Reviews Oxsoralen-Ultra

Oxsoralen-Ultra Drug Description Oxoralen-Ultra® (methoxsalen) Capsules, USP, 10 mg CAUTION: METHOXSALEN IS A POTENT DRUG. READ ENTIRE BROCHURE PRIOR TO PRESCRIBING OR DISPENSING THIS MEDICATION. Methoxsalen with UV radiation...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....